We are live on ! Find out more
SYRS icon

Syros Pharmaceuticals, Inc. Common Stock

Delisted

SYRS was delisted on the 19th of March, 2025.

Name Holding Trade Value Shares
Change
Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$49.3M +$194K +3,286 +0.4%
BCLSI
2
Bain Capital Life Sciences Investors
Massachusetts
$31.5M – – –
BlackRock
3
BlackRock
New York
$24.3M +$1.75M +29,540 +7%
ABG
4
Ally Bridge Group
New York
$18.7M +$1.78M +30,000 +10%
FP
5
Flagship Pioneering
Massachusetts
$16M – – –
Vanguard Group
6
Vanguard Group
Pennsylvania
$15.1M +$255K +4,316 +2%
OFM
7
Omega Fund Management
Massachusetts
$12.4M +$4.22M +71,233 +46%
SB
8
Samsara BioCapital
California
$10.6M – – –
OrbiMed
9
OrbiMed
New York
$10M – – –
AG
10
Artal Group
Luxembourg
$9.27M +$4M +67,500 +66%
ACM
11
Altium Capital Management
New York
$5.87M +$5.62M +95,024 +750%
EC
12
EcoR1 Capital
California
$5.45M – – –
State Street
13
State Street
Massachusetts
$5.45M +$1.21M +20,390 +26%
Geode Capital Management
14
Geode Capital Management
Massachusetts
$5.27M +$790K +13,344 +16%
RA Capital Management
15
RA Capital Management
Massachusetts
$4.91M – – –
Adage Capital Partners
16
Adage Capital Partners
Massachusetts
$4.64M +$5.04M +85,230 New
SCM
17
Sio Capital Management
New York
$4.36M +$4.74M +80,000 New
Candriam SCA
18
Candriam SCA
Luxembourg
$3.18M +$3.46M +58,427 New
Millennium Management
19
Millennium Management
New York
$3.04M +$2.3M +38,892 +230%
Northern Trust
20
Northern Trust
Illinois
$3.02M +$204K +3,451 +7%
Goldman Sachs
21
Goldman Sachs
New York
$2.73M -$803K -13,570 -21%
Morgan Stanley
22
Morgan Stanley
New York
$2.2M +$173K +2,921 +8%
Charles Schwab
23
Charles Schwab
California
$2.14M +$169K +2,863 +8%
Acadian Asset Management
24
Acadian Asset Management
Massachusetts
$1.93M +$2.1M +35,445 New
Dimensional Fund Advisors
25
Dimensional Fund Advisors
Texas
$1.68M -$252K -4,252 -12%